Beijing, Beijing, China Related Funds
| Fund Name | Location |
| Addition | New York, New York, United States |
| Arnel Capital Management | - |
| Blue Chip Capital | - |
| C&D Co. | - |
| Cairn Investment Group | - |
| Chan Brothers Group | Central, Central Region, Singapore |
| Cinda Securities | Beijing, Beijing, China |
| GAIL | Delhi, India, New Delhi |
| Guardian | - |
| Hangzhou Mien Touzi Hehuo Qiye (Youxian Hehuo) | China, Hangzhou, Zhejiang |
| J-POWER | Japan, Tokyo |
| Jumpstart Capital | Nashville, Tennessee, United States |
| Metroworks Equity | - |
| Phoenix Contact Innovation Ventures | Blomberg, Germany, Nordrhein-Westfalen |
| Rolling Oaks Capital | California, United States, Venice |
| ROTH Capital Partners | California, Newport Beach, United States |
| Shenzhen Qianhai Jincai Financial Holdings | China, Guangdong, Shenzhen |
| Starburst Ventures | France, Ile-de-France, Paris |
| Tynwald Investments | Connecticut, New York, United States |
| University of Southampton Future Worlds Incubator | England, Southampton, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CANbridge Pharmaceuticals | $25M | 23 May 2017 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CANbridge Pharmaceuticals | $25M | 23 May 2017 | Dongcheng District, Beijing, China |
